Innovate with
Symposium Lab

Innovate with
Symposium Lab

Innovate with
Symposium Lab

At Symposium, we provide customers with data intelligence on research that power tomorrow’s healthcare.

At Symposium, we provide customers with data intelligence on research that power tomorrow’s healthcare.

Biotech + Pharma

Biotech + Pharma

Optimize Clinical Trial Design

Optimize Clinical Trial Design

Our Symposium Trialist platform delivers both descriptive and predictive analytics that streamline patient recruitment, enhance protocol design, and forecast potential trial challenges.

Our Symposium Trialist platform delivers both descriptive and predictive analytics that streamline patient recruitment, enhance protocol design, and forecast potential trial challenges.

Our Unique Approach

Our Unique Approach

AI + Expert

Artificial Generative Clinical Trial Intelligence (AGCI)

AGCI is the pioneering solution that revolutionizes clinical trial design. The system provides unparalleled insights to realize more efficient, cost-effective, and successful clinical trials rooted in real data and solid science.

Artificial Generative Clinical Trial Intelligence (AGCI)

AGCI is the pioneering solution that revolutionizes clinical trial design. The system provides unparalleled insights to realize more efficient, cost-effective, and successful clinical trials rooted in real data and solid science.

ResearchTrack: Domain Expert Database

Human capital cannot be overlooked in life science R&D. The value of technology amplifies when the right people are using it. ResearchTrack enables precise identification and objective evaluation of scientists.

ResearchTrack: Domain Expert Database

Human capital cannot be overlooked in life science R&D. The value of technology amplifies when the right people are using it. ResearchTrack enables precise identification and objective evaluation of scientists.

Powered by ResearchTrack

Powered by ResearchTrack

We help research institutions and enterprises gain actionable insights through our data engine that automates data aggregation, integration, and analytics.

We help research institutions and enterprises gain actionable insights through our data engine that automates data aggregation, integration, and analytics.

Biotech + Pharma

Identify Capable Principal Investigators

Biotech + Pharma

Identify Capable Principal Investigators

Biotech + Pharma

Identify Capable Principal Investigators

STM Publishers

Ensure Research Publication Integrity

STM Publishers

Ensure Research Publication Integrity

STM Publishers

Ensure Research Publication Integrity

Grant-Making Foundations

Improve Grant Funding Allocation

Grant-Making Foundations

Improve Grant Funding Allocation

Grant-Making Foundations

Improve Grant Funding Allocation

Products

Products

Support experience that customers actually appreciate.

Support experience that customers actually appreciate.

Product1

Product2

Product3

Product4

Product1

Product2

Product3

Product4

Product1

Product2

Product3

Product4

Powering AI-assisted decision making — from labs to board rooms.

Powering AI-assisted decision making — from labs to board rooms.

Insights of Tomorrow Delivered Today

Insights of Tomorrow Delivered Today

1

Discover future scenarios for the DeepTech economy

1

Discover future scenarios for the DeepTech economy

2

Explore innovations driving the Life Sciences industry

2

Explore innovations driving the Life Sciences industry

3

Track investment trends and deal flows

3

Track investment trends and deal flows

4

Stay on top of emerging bench-to-bedside opportunities

4

Stay on top of emerging bench-to-bedside opportunities

Actionable Insights for All

Actionable Insights for All

Boston

Vancouver

Shanghai

Sans Francisco

Toronto

Beijing

A New Age of Data for Research and Innovation

A New Age of Data for Research and Innovation

In the News

In the News

The findings question the rationale behind current funding trends and point toward more efficient ways to allocate resources. In addition, they highlight the need for more research on the interplay between science-internal mechanisms and policy priorities in accelerating concentration of funding.

Concentration or dispersal of research funding?

Kaare Aagaard, Alexander Kladakis, Mathias W. Nielsen

The findings question the rationale behind current funding trends and point toward more efficient ways to allocate resources. In addition, they highlight the need for more research on the interplay between science-internal mechanisms and policy priorities in accelerating concentration of funding.

Concentration or dispersal of research funding?

Kaare Aagaard, Alexander Kladakis, Mathias W. Nielsen

To address this new evidence, NIH will be implementing an additional measure to bring the workforce back into equilibrium by working with NIH grant applicants/recipients to limit the total NIH grant support provided to an individual principal investigator through NIH-supported research. We call it the Grant Support Index (GSI).

New NIH Approach to Grant Funding Aimed at Optimizing Stewardship of Taxpayer Dollars

Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health

To address this new evidence, NIH will be implementing an additional measure to bring the workforce back into equilibrium by working with NIH grant applicants/recipients to limit the total NIH grant support provided to an individual principal investigator through NIH-supported research. We call it the Grant Support Index (GSI).

New NIH Approach to Grant Funding Aimed at Optimizing Stewardship of Taxpayer Dollars

Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health

With millions of scientific papers published every year and more than $2 trillion invested annually in research and development, scientists make plenty of progress. But could we do better? There is increasing evidence that some of the ways we conduct, evaluate, report and disseminate research are miserably ineffective.

Science Funding Is Broken

John P. A. Ioannidis

With millions of scientific papers published every year and more than $2 trillion invested annually in research and development, scientists make plenty of progress. But could we do better? There is increasing evidence that some of the ways we conduct, evaluate, report and disseminate research are miserably ineffective.

Science Funding Is Broken

John P. A. Ioannidis

Explore the all-in-one innovation intelligence platform

OFFICE

548 Market St

San Francisco, California

94104 US

© Symposium Lab™. All rights reserved.

OFFICE

548 Market St

San Francisco, California

94104 US

© Symposium Lab™. All rights reserved.

OFFICE

548 Market St

San Francisco, California

94104 US

© Symposium Lab™. All rights reserved.